[clinicaltrials_resource:0017633a243a73b043c5a0181e67993a]
clinicaltrials:NCT00548431clinicaltrials:NCT00816049clinicaltrials:NCT00819351clinicaltrials:NCT01393249Second Malignant Neoplasms After Childhood ALL Therapy [clinicaltrials:NCT01476462]The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia [clinicaltrials:NCT01886651]Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL [clinicaltrials:NCT01896752]
responsible party [clinicaltrials_vocabulary:responsible-party]
[clinicaltrials_resource:0017633a243a73b043c5a0181e67993a]
Bio2RDF identifier
0017633a243a73b043c5a0181e67993a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0017633a243a73b043c5a0181e67993a
investigator affiliation [clinicaltrials_vocabulary:investigator-affiliation]
Rigshospitalet, Denmark
investigator full name [clinicaltrials_vocabulary:investigator-full-name]
Kjeld Schmiegelow
investigator title [clinicaltrials_vocabulary:investigator-title]
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:0017633a243a73b043c5a0181e67993a
type
label
[clinicaltrials_resource:0017633a243a73b043c5a0181e67993a]
@en